Research has shown that CD44 has a protective effect in hyperoxia- and LPS-induced ALI and that CD44 deficiency results in a significant influx of inflammatory cells and increased chemokine expression in the broncho-alveolar lavage fluid (BALF) (104, 105). The gene discussed is CD44; the disease is acute respiratory distress syndrome.